22 Jul 2016 09:52
NMC Health plc
NOTIFICATION MADE IN ACCORDANCE WITH RULE 3.1.4 (1) (a) OF THE
DISCLOSURE AND TRANSPARENCY RULES
London, 22 July 2016: NMC Health plc (LSE:NMC) ('NMC'), the leading integrated private healthcare provider operating across the United Arab Emirates and one of the top global providers of fertility treatments through its Spanish subsidiary Clinica Eugin, announces that it received notification on 21 July 2016 from Mr Mark Tompkins, Chairman of the Company, that on 20 July 2016, the following transactions changed the nature of his interest over NMC shares:
| No. of shares | Price paid (p) | Price received (p) | Purchase/sale |
|
|
|
|
|
Mrs S. Tompkins (1) | 5,000 | N/A | 1095.72 | Sale of shares |
Tompkins Family Trust (2) | 5,000 | 1119.98 | N/A | Purchase of shares |
Notes:
(1) The shares were sold from an ISA account held by Mr Tompkins' wife
(2) The shares purchased were acquired by a family trust of which Mr Tompkins is a potential beneficiary.
As a result of these transactions, Mr Tompkins' interest in the shares of the Company remains unchanged at 25,083 shares, representing 0.01% of the current issued share capital of the Company, including Mrs Sarah Tompkins' direct interest in the shares of the Company of 2,983 shares, representing 0.002% of the current issued share capital of the Company, and 13,000 shares, representing 0.007% of the current issued share capital of the Company, owned by a family trust of which Mr Tompkins is a potential beneficiary.
Contacts
Investors
NMC
Simon Watkins, Group Company Secretary +44 (0)20 3205 7313
Media:
FTI Consulting, London
Matthew Cole +44 (0)20 3727 1101
FTI Consulting, Gulf
Shane Dolan +971 (0)4 437 2100
NMC.L (NMC)